Dr Mike Tubbs
For decades, Dr Mike Tubbs worked on the 'inside' of corporate giants such as Xerox, Battelle and Lucas. Working in the research and development departments, he learnt what became the key to his investing. Knowledge which gave him a unique perspective on the stock markets.
Dr Tubbs went on to create the R&D Scorecard which was presented annually to the Department of Trade & Industry and the European Commission. It was a guide for European businesses on how to improve prospects using correctly applied research and development.
Latest articles by Dr Mike Tubbs
-
Lockheed Martin: the world’s best defence stock
Tips Lockheed Martin is the industry’s most diversified top-quality company and a robust pick in tough times.
By Dr Mike Tubbs Published
Tips -
Where to find "ten-bagger" stocks – the market's Holy Grail
Cover Story “Ten-baggers,” stocks with the potential to rise tenfold, are rare but not impossible to find. Dr Mike Tubbs explores their key characteristics and suggests where you should start your search
By Dr Mike Tubbs Last updated
Cover Story -
Gilead's anti-viral expertise will stand it well
Tips There is far more to biotech giant Gilead Sciences than its potential treatment for Covid-19; it has expertise in anti-virals against a wide range of the world’s dangerous diseases.
By Dr Mike Tubbs Published
Tips -
This high quality engineering firm will filter profits to investors
Tips Porvair, a maker of high-tech filtration systems, is an excellent long-term pick for your investment portfolio.
By Dr Mike Tubbs Published
Tips -
Secret sauce: the key to serial innovation and profit growth
Cover Story Why do some companies fizzle out and fade away while others build on a strong start? Dr Mike Tubbs looks at the key factors behind sustainable success and highlights his favourite consistent performers.
By Dr Mike Tubbs Published
Cover Story -
Stocks that offer two sectors for the price of one
Analysis There are several excellent companies that dabble in two very different markets. Dr Mike Tubbs highlights the ones worth considering now.
By Dr Mike Tubbs Published
Analysis -
How stem cells are changing the face of medicine
Features We have only just started getting to grips with the vast life-saving potential of stem cells, the basic building blocks of the body. Dr Mike Tubbs explores recent breakthroughs and assesses the state of the market.
By Dr Mike Tubbs Published
Features -
Engineering profits: the British industrial champions to buy now
Cover Story Move over, Germany and Sweden. There are several world-class UK engineers in profitable niches supplying a vast array of industries with vital equipment. Dr Mike Tubbs picks his favourites.
By Dr Mike Tubbs Published
Cover Story -
Swedish engineer Hexagon is in excellent shape
Features This Swedish engineer has been overshadowed by bigger local peers, but is well worth a look
By Dr Mike Tubbs Published
Features -
Where to find and how to invest in founder-managed firms
Tutorials Companies that are set up and then run by the same person for a long time tend to be lucrative investments. Dr Mike Tubbs explains why, how to find founder-managed firms, and which ones to buy now.
By Dr Mike Tubbs Published
Tutorials -
Diploma qualifies for your portfolio
Features This British mid-cap is a successful global player with plenty of room for expansion, says Dr Mike Tubbs.
By Dr Mike Tubbs Published
Features -
Immunotherapy: new hope in the battle against cancer
Cover Story Immunotherapy is a burgeoning sector that heralds a breakthrough against the world’s second-most deadly disease. Dr Mike Tubbs explains how investors can benefit too.
By Dr Mike Tubbs Published
Cover Story -
Alexion: a rare opportunity in biotech
Features Alexion focuses on diseases that affect only a tiny proportion of the population – a lucrative niche.
By Dr Mike Tubbs Published
Features -
Illumina: shedding light on genetics
Features Illumina, the genome sequencing specialist, is a leader in a thriving market. Long-term investors should buy now, says Mike Tubbs.
By Dr Mike Tubbs Published
Features -
R&D: the key to long-term sales and profit growth
Tutorials Companies that spend heavily on research and development (R&D) greatly improve their long-term odds. Dr Mike Tubbs explains what to look out for – and what to buy now.
By Dr Mike Tubbs Published
Tutorials -
The strong and stable stocks offering a reliable income
Tutorials Companies with a consistent record of rising payouts look especially attractive at present. Dr Mike Tubbs introduces his favourite “dividend aristocrats”.
By Dr Mike Tubbs Published
Tutorials -
Profit from Renishaw’s precision
Features Few people have heard of Renishaw, but its products and prospects are excellent, says Mike Tubbs.
By Dr Mike Tubbs Published
Features -
Salesforce: software service with a smile
Features Salesforce, one of the world’s top software companies, has a bright future and is currently on sale.
By Dr Mike Tubbs Published
Features -
Profits in the pipeline
Features Shares in German biotech MorphoSys firm could double as the royalties start to roll in, says Mike Tubbs.
By Dr Mike Tubbs Published
Features -
The British software sector stars investors should buy now
Cover Story You might not think of the UK as a market full of promising tech stocks. But our small- and medium-sized companies are punching above their weight, says Dr Mike Tubbs.
By Dr Mike Tubbs Published
Cover Story -
A memorable day for Biogen investors
Features Biotech company Biogen’s promising treatment for the most common cause of dementia has just cleared a key hurdle.
By Dr Mike Tubbs Published
Features -
Protect your profits – buy firms with deep and wide moats
Tutorials Firms with strong brands, superior products or that exploit network effects are hard for competitors to keep up with. That means big profits for their investors. Mike Tubbs picks the best protected companies.
By Dr Mike Tubbs Published
Tutorials -
RWS: translating tech into profits
Features RWS is a “picks-and-shovels” play for the technology sector, and boasts an excellent record, says Mike Tubbs.
By Dr Mike Tubbs Published
Features -
The fledgling industries emerging from our universities
Tutorials Science and engineering departments are innovation incubators, and regularly launch companies involved in a wide range of exciting new fields. Dr Mike Tubbs explains how to invest in spin-outs.
By Dr Mike Tubbs Published
Tutorials